Therapeutic Small Molecules Target Inhibitor of Apoptosis Proteins in Cancers with Deregulation of Extrinsic and Intrinsic Cell Death Pathways

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Clinical Cancer Research

• Publication date

  2016-12-30

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1158/1078-0432.CCR-16-2172PMID 28039268PMCID PMC5354945
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cytotoxic effects of SMAC-mimetic compound LCL161 in head and neck cancer cell lines

  2016cited by this paper
• SMAC Mimetic Birinapant plus Radiation Eradicates Human Head and Neck Cancers with Genomic Amplifications of Cell Death Genes FADD and BIRC2.

  2016cited by this paper
• A Phase I Study of the SMAC-Mimetic Birinapant in Adults with Refractory Solid Tumors or Lymphoma

  2015cited by this paper
• The future of cancer genomics

  2015cited by this paper
• Promises and Challenges of Smac Mimetics as Cancer Therapeutics

  2015cited by this paper
• Necroptosis and its role in inflammation

  2015cited by this paper
• Smac mimetics as IAP antagonists.

  2015cited by this paper
• Comprehensive genomic characterization of head and neck squamous cell carcinomas

  2015cited by this paper
• Targeting extrinsic apoptosis in cancer: Challenges and opportunities.

  2015cited by this paper
• The radiosensitizing activity of the SMAC-mimetic, Debio 1143, is TNFα-mediated in head and neck squamous cell carcinoma.

  2015cited by this paper
• Combination effects of SMAC mimetic birinapant with TNFα, TRAIL, and docetaxel in preclinical models of HNSCC

  2015cited by this paper
• Safety, pharmacokinetics, and pharmacodynamic properties of oral DEBIO1143 (AT-406) in patients with advanced cancer: results of a first-in-man study

  2015cited by this paper
• Small-molecule SMAC mimetics as new cancer therapeutics.

  2014cited by this paper
• Phase I dose-escalation study of LCL161, an oral inhibitor of apoptosis proteins inhibitor, in patients with advanced solid tumors.

  2014cited by this paper
• Multiplatform analysis of 12 cancer types reveals molecular classification within and across tissues of origin.

  2014cited by this paper
• Birinapant (TL32711), a Bivalent SMAC Mimetic, Targets TRAF2-Associated cIAPs, Abrogates TNF-Induced NF-κB Activation, and Is Active in Patient-Derived Xenograft Models

  2014influential reference
• The Future of Cancer Genomics

  2014cited by this paper
• Differential response of head and neck cancer cell lines to TRAIL or Smac mimetics is associated with the cellular levels and activity of caspase-8 and caspase-10

  2014influential reference
• Learning and Confirming with Preclinical Studies: Modeling and Simulation in the Discovery of GDC-0917, an Inhibitor of Apoptosis Proteins Antagonist

  2013influential reference
• Cyclin D1 overexpression is associated with poor prognosis in oropharyngeal cancer

  2013cited by this paper
• Small-Molecule IAP Antagonists Sensitize Cancer Cells to TRAIL-Induced Apoptosis: Roles of XIAP and cIAPs

  2013cited by this paper
• The roles of FADD in extrinsic apoptosis and necroptosis.

  2012cited by this paper
• Alterations in tumor necrosis factor signaling pathways are associated with cytotoxicity and resistance to taxanes: a study in isogenic resistant tumor cells

  2012cited by this paper
• Targeting IAP proteins for therapeutic intervention in cancer

  2012cited by this paper
• Discovery of a potent small-molecule antagonist of inhibitor of apoptosis (IAP) proteins and clinical candidate for the treatment of cancer (GDC-0152).

  2012influential reference
• Ubiquitination and degradation of the FADD adaptor protein regulate death receptor-mediated apoptosis and necroptosis

  2012cited by this paper
• Smac Modulates Chemosensitivity in Head and Neck Cancer Cells through the Mitochondrial Apoptotic Pathway

  2011cited by this paper
• Hallmarks of cancer: the next generation.

  2011cited by this paper
• Cyclin D as a therapeutic target in cancer

  2011cited by this paper
• Non-canonical NF-κB signaling pathway

  2011cited by this paper
• Ubiquitylation in apoptosis: a post-translational modification at the edge of life and death

  2011cited by this paper
• Cyclin D1 and FADD as Biomarkers in Head and Neck Squamous Cell Carcinoma

  2011cited by this paper
• Radiosensitization of Head and Neck Squamous Cell Carcinoma by a SMAC-Mimetic Compound, SM-164, Requires Activation of Caspases

  2011cited by this paper
• A potent and orally active antagonist (SM-406/AT-406) of multiple inhibitor of apoptosis proteins (IAPs) in clinical development for cancer treatment.

  2011influential reference
• Therapeutic Potential and Molecular Mechanism of a Novel, Potent, Nonpeptide, Smac Mimetic SM-164 in Combination with TRAIL for Cancer Treatment

  2011cited by this paper
• Smac mimetics increase cancer cell response to chemotherapeutics in a TNF-α-dependent manner

  2010cited by this paper
• Mitochondria and cell death: outer membrane permeabilization and beyond

  2010cited by this paper
• c‐IAP1 and UbcH5 promote K11‐linked polyubiquitination of RIP1 in TNF signalling

  2010cited by this paper
• Cellular IAPs inhibit a cryptic CD95-induced cell death by limiting RIP1 kinase recruitment

  2009influential reference
• The E3 Ubiquitin Ligase cIAP1 Binds and Ubiquitinates Caspase-3 and -7 via Unique Mechanisms at Distinct Steps in Their Processing*

  2009cited by this paper
• RIP kinases at the crossroads of cell death and survival.

  2009cited by this paper
• Activation of noncanonical NF-κB requires coordinated assembly of a regulatory complex of the adaptors cIAP1, cIAP2, TRAF2, TRAF3 and the kinase NIK

  2008cited by this paper
• cIAP1 and cIAP2 facilitate cancer cell survival by functioning as E3 ligases that promote RIP1 ubiquitination.

  2008cited by this paper
• Nonredundant and complementary functions of TRAF2 and TRAF3 in a ubiquitination cascade that activates NIK-dependent alternative NF-κB signaling

  2008cited by this paper
• The mitochondrial serine protease HtrA2/Omi: an overview

  2008cited by this paper
• Regulation of TNFR1 and CD95 signalling by receptor compartmentalization

  2008cited by this paper
• IAP antagonists target cIAP1 to induce TNFalpha-dependent apoptosis.

  2007influential reference
• Apoptosis: A Review of Programmed Cell Death

  2007cited by this paper
• Faculty Opinions recommendation of IAP antagonists induce autoubiquitination of c-IAPs, NF-kappaB activation, and TNFalpha-dependent apoptosis.

  2007influential reference
• IAP antagonists induce autoubiquitination of c-IAPs, NF-kappaB activation, and TNFalpha-dependent apoptosis.

  2007cited by this paper
• XAF1 Mediates Tumor Necrosis Factor-α-induced Apoptosis and X-linked Inhibitor of Apoptosis Cleavage by Acting through the Mitochondrial Pathway*

  2007cited by this paper
• A Smac mimetic rescue screen reveals roles for inhibitor of apoptosis proteins in tumor necrosis factor-alpha signaling.

  2007cited by this paper
• Regulation and Function of IKK and IKK-Related Kinases

  2006cited by this paper
• The Human Anti-apoptotic Proteins cIAP1 and cIAP2 Bind but Do Not Inhibit Caspases*

  2006cited by this paper
• Introduction to NF-kappaB: players, pathways, perspectives.

  2006cited by this paper
• Human inhibitor of apoptosis proteins: why XIAP is the black sheep of the family

  2006cited by this paper
• IAPs, RINGs and ubiquitylation

  2005cited by this paper
• The mitochondrial ARTS protein promotes apoptosis through targeting XIAP

  2004cited by this paper
• Mechanism of XIAP-mediated inhibition of caspase-9.

  2003cited by this paper
• A decade of caspases

  2003cited by this paper
• The TNF receptor 1: a split personality complex.

  2003cited by this paper
• IAP proteins: blocking the road to death's door

  2002cited by this paper
• Structural basis of caspase-7 inhibition by XIAP.

  2001cited by this paper
• Structural basis for the inhibition of caspase-3 by XIAP.

  2001cited by this paper
• TNF-alpha gene expression in macrophages: regulation by NF-kappa B is independent of c-Jun or C/EBP beta.

  2000cited by this paper
• Structural basis of IAP recognition by Smac/DIABLO

  2000cited by this paper
• The biochemistry of apoptosis

  2000influential reference
• Structural basis for binding of Smac/DIABLO to the XIAP BIR3 domain

  2000cited by this paper
• Structural and biochemical basis of apoptotic activation by Smac/DIABLO

  2000cited by this paper
• Activation of NF-kappaB by FADD, Casper, and caspase-8.

  2000cited by this paper
• TNF-α Gene Expression in Macrophages: Regulation by NF-κB Is Independent of c-Jun or C/EBPβ1

  2000cited by this paper
• Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition.

  2000cited by this paper
• An exegesis of IAPs: salvation and surprises from BIR motifs.

  1999cited by this paper
• Cytotoxicity‐dependent APO‐1 (Fas/CD95)‐associated proteins form a death‐inducing signaling complex (DISC) with the receptor.

  1995cited by this paper
• An apoptosis-inhibiting baculovirus gene with a zinc finger-like motif

  1993cited by this paper
• Regulation of tumor necrosis factor alpha transcription in macrophages: involvement of four kappa B-like motifs and of constitutive and inducible forms of NF-kappa B

  1990cited by this paper

• Cancer neuroscience: signaling pathways and new therapeutic strategies for cancer

  2026cites this paper
• IAP Antagonists Selectively Eliminate Therapy-Induced Senescent Cancer Cells via TNFα-Independent Apoptosis.

  2026cites this paper
• Non-coding RNA as a key regulator and novel target of apoptosis in diabetic cardiomyopathy: Current status and future prospects.

  2025cites this paper
• Silencing Livin gene expression by RNA interference enhanced the chemotherapeutic sensitivity of drug-resistant osteosarcoma cells to doxorubicin.

  2025cites this paper
• Parthanatos and apoptosis: unraveling their roles in cancer cell death and therapy resistance

  2025cites this paper
• MDM2 inhibitor induces apoptosis in colon cancer cells through activation of the CHOP-DR5 pathway, independent of p53 phenotype

  2025cites this paper
• Specific signaling pathways mediated programmed cell death in tumor microenvironment and target therapies

  2025cites this paper
• Computational investigation of stigmasterol as a potential therapeutic agent for cervical cancer: insights from density functional theory (DFT) and molecular docking studies

  2025cites this paper
• CRISPR-Cas9 Genome and Double-Knockout Screening to Identify Novel Therapeutic Targets for Chemoresistance in Triple-Negative Breast Cancer

  2025cites this paper
• mTORC1 inhibition by metformin synergizes with dendrosomal nano-curcumin to induce apoptosis via modulation of pro- and anti-apoptotic proteins in breast cancer cells

  2025cites this paper
• Immunohistochemical Expression of Baculoviral Inhibitor of Apoptotic Proteins Repeat-Containing Protein in Tumors of Salivary Gland Origin

  2025cites this paper
• CRISPR Double Knockout Library Reveals Synthetic Lethal Gene Pairs in Triple-Negative Breast Cancer

  2024cites this paper
• Accelerating CAR-T Cell Therapies with Small-Molecule Inhibitors

  2024cites this paper
• Beclin-1: a therapeutic target at the intersection of autophagy, immunotherapy, and cancer treatment

  2024cites this paper
• Advancements in programmed cell death research in antitumor therapy: a comprehensive overview

  2024cites this paper
• Pan-cell death-related signature reveals tumor immune microenvironment and optimizes personalized therapy alternations in lung adenocarcinoma

  2024cites this paper
• Exploring Ubiquitin-specific proteases as therapeutic targets in Glioblastoma.

  2024cites this paper
• Comprehensive study of molecular mechanism in Cervical Cancer cell death in vitro and in vivo induced by Phytochemicals

  2024cites this paper
• An Overview of Cancer Biology, Pathophysiological Development and It’s Treatment Modalities: Current Challenges of Cancer anti-Angiogenic Therapy

  2024cites this paper
• Overcoming Resistance to Standard-of-Care Therapies for Head and Neck Squamous Cell Carcinomas

  2024cites this paper
• Evasion of apoptosis and treatment resistance in squamous cell carcinoma of the head and neck.

  2024cites this paper
• Metabolic pathway-based subtypes associate glycan biosynthesis and treatment response in head and neck cancer

  2024cites this paper
• A promising future of metal‐N‐heterocyclic carbene complexes in medicinal chemistry: The emerging bioorganometallic antitumor agents

  2024cites this paper
• SMAC Mimetics for the Treatment of Lung Carcinoma: Present Development and Future Prospects.

  2024cites this paper
• Efficient treatment of colon cancer with codelivery of TRAIL and imatinib by liposomes

  2024cites this paper
• The expanding role of IAP antagonists for the treatment of head and neck cancer

  2023cites this paper
• IMPA2 blocks cervical cancer cell apoptosis and induces paclitaxel resistance through p53-mediated AIFM2 regulation

  2023cites this paper
• Insight on common forms of cutaneous head and neck carcinoma (Review).

  2023cites this paper
• Oncoviruses: Induction of cancer development and metastasis by increasing anoikis resistance

  2023cites this paper
• Combined Inhibition of IAPs and WEE1 Enhances TNFα- and Radiation-Induced Cell Death in Head and Neck Squamous Carcinoma

  2023cites this paper
• Computational design of newly engineered DARPins as HER2 receptor inhibitors for breast cancer treatment

  2023cites this paper
• Targeted therapy for non‐small‐cell lung cancer: New insights into regulated cell death combined with immunotherapy

  2023cites this paper
• Melatonin as a regulator of apoptosis in leukaemia: molecular mechanism and therapeutic perspectives

  2023cites this paper
• Identification of disulfidptosis-related subtypes, characterization of tumor microenvironment infiltration, and development of a prognosis model in colorectal cancer

  2023cites this paper
• Advances in tumor nanotechnology: theragnostic implications in tumors via targeting regulated cell death

  2023cites this paper
• Eprinomectin: a derivative of ivermectin suppresses growth and metastatic phenotypes of prostate cancer cells by targeting the β-catenin signaling pathway

  2023cites this paper
• Combination of Nisin and Glabridin Enhanced Apoptosis in Colorectal Cancer Cells

  2023cites this paper
• The Study on the Effect and Mechanism of Crocin against Human Ewing Sarcoma

  2022cites this paper
• Regulated cell death (RCD) in cancer: key pathways and targeted therapies

  2022cites this paper
• Conjugation of the Fn14 ligand to a SMAC mimetic selectively suppresses experimental squamous cell carcinoma in mice.

  2022cites this paper
• Targeting regulated cell death (RCD) with small-molecule compounds in triple-negative breast cancer: a revisited perspective from molecular mechanisms to targeted therapies

  2022cites this paper
• Evaluation of a Dual PI3K/mTOR Inhibitor PF-04691502 against Bladder Cancer Cells

  2022cites this paper
• Evaluation of the Cytotoxicity of Aqueous Extract and Oleo-Essential Oil of Dorema ammoniacum Plant Oleo-Gum Resin in Some Human Cancer Cell Lines

  2022cites this paper
• Naturally derived indole alkaloids targeting regulated cell death (RCD) for cancer therapy: from molecular mechanisms to potential therapeutic targets

  2022cites this paper
• Research progress on pyroptosis-mediated immune-inflammatory response in ischemic stroke and the role of natural plant components as regulator of pyroptosis: A review.

  2022cites this paper
• CLEFMA Induces the Apoptosis of Oral Squamous Carcinoma Cells through the Regulation of the P38/HO-1 Signalling Pathway

  2022cites this paper
• Protein Kinase N2 Reduces Hydrogen Peroxide-inducedDamage and Apoptosis in PC12 Cells by AntiOxidative Stress and Activation of the mTOR Pathway

  2022cites this paper
• In vitro anti-synovial sarcoma effect of diallyl trisulfide and mRNA profiling.

  2022cites this paper
• Perkinsus marinus suppresses in vitro eastern oyster apoptosis via IAP-dependent and caspase-independent pathways involving TNFR, NF-kB, and oxidative pathway crosstalk.

  2022cites this paper
• Cell Death: a Molecular Perspective

  2021cites this paper
• An Overview of Novel Agents for Cervical Cancer Treatment by Inducing Apoptosis: Emerging Drugs Ongoing Clinical Trials and Preclinical Studies

  2021cites this paper
• Chlorogenic acid inhibits apoptosis in thiram-induced tibial dyschondroplasia via intrinsic pathway

  2021cites this paper
• Ubiquitin D Promotes Progression of Oral Squamous Cell Carcinoma via NF-Kappa B Signaling

  2021cites this paper
• Molecular Markers of MDR of Chemotherapy for HSCC: Proteomic Screening With High-Throughput Liquid Chromatography-Tandem Mass Spectrometry

  2021cites this paper
• Dehydrocrenatidine extracted from Picrasma quassioides induces the apoptosis of nasopharyngeal carcinoma cells through the JNK and ERK signaling pathways

  2021cites this paper
• Novel Role of IMPA2 in AIFM2-Mediated Apoptosis of Cervical Cancer by Targeting p53

  2021cites this paper
• cIAP1/2 antagonism eliminates MHC class I–negative tumors through T cell–dependent reprogramming of mononuclear phagocytes

  2021cites this paper
• A novel dual HDAC and HSP90 inhibitor, MPT0G449, downregulates oncogenic pathways in human acute leukemia in vitro and in vivo

  2021cites this paper
• A self-sustained nanoplatform reverses TRAIL-resistance of pancreatic cancer through coactivating of exogenous and endogenous apoptotic pathway.

  2021cites this paper
• Theasaponin E1 Inhibits Platinum-Resistant Ovarian Cancer Cells through Activating Apoptosis and Suppressing Angiogenesis

  2021cites this paper
• The non‐peptidomimetic IAP antagonist ASTX660 sensitizes colorectal cancer cells for extrinsic apoptosis

  2021cites this paper
• Transcriptomic Profiling of In Vitro Tumor-Stromal Cell Paracrine Crosstalk Identifies Involvement of the Integrin Signaling Pathway in the Pathogenesis of Mesenteric Fibrosis in Human Small Intestinal Neuroendocrine Neoplasms

  2021cites this paper
• Ambivalent Effects of Tumor Necrosis Factor Alpha on Apoptosis of Malignant and Normal Human Keratinocytes

  2021cites this paper
• Death agonist antibody against TRAILR2/DR5/TNFRSF10B enhances birinapant anti-tumor activity in HPV-positive head and neck squamous cell carcinomas

  2021cites this paper
• Role of inflammatory microenvironment: potential implications for improved breast cancer nano-targeted therapy

  2021cites this paper
• Proinflammatory Signaling Pathways and Genomic Signatures in Head and Neck Cancers

  2021cites this paper
• Genomic and transcriptomic alterations in m6A regulatory genes are associated with tumorigenesis and poor prognosis in head and neck squamous cell carcinoma.

  2021cites this paper
• ANTP-SMACN7 fusion peptide alone induced high linear energy transfer irradiation radiosensitization in non-small cell lung cancer cell lines

  2021cites this paper
• Apoptosis and its therapeutic implications in neurodegenerative diseases

  2021cites this paper
• Targeted Chemotherapy

  2021cites this paper
• Killing by Degradation: Regulation of Apoptosis by the Ubiquitin-Proteasome-System

  2021cites this paper
• Tipos de muerte celular y sus implicaciones clínicas

  2020cites this paper
• Influence of tumour necrosis factor alpha on epithelial-mesenchymal transition of oral cancer cells in co-culture with mesenchymal stromal cells.

  2020cites this paper
• A Phase I Study of ASTX660, an Antagonist of Inhibitors of Apoptosis Proteins, in Adults with Advanced Cancers or Lymphoma

  2020cites this paper
• ASTX660, an antagonist of cIAP1/2 and XIAP, increases antigen processing machinery and can enhance radiation-induced immunogenic cell death in preclinical models of head and neck cancer

  2020cites this paper
• Targeting XIAP for Promoting Cancer Cell Death—The Story of ARTS and SMAC

  2020cites this paper
• Dual Targeting of the p38 MAPK-HO-1 Axis and cIAP1/XIAP by Demethoxycurcumin Triggers Caspase-Mediated Apoptotic Cell Death in Oral Squamous Cell Carcinoma Cells

  2020influential citation
• Bcl-xL overexpression decreases GILZ levels and inhibits glucocorticoid-induced activation of caspase-8 and caspase-3 in mouse thymocytes

  2020cites this paper
• Targeting apoptosis in cancer therapy

  2020cites this paper
• Double agents of cell death: novel emerging functions of apoptotic regulators

  2020cites this paper
• Targeting the Extrinsic Pathway of Hepatocyte Apoptosis Promotes Clearance of Plasmodium Liver Infection.

  2020cites this paper
• Mechanistic Study of Triazole Based Aminodiol Derivatives in Leukemic Cells—Crosstalk between Mitochondrial Stress-Involved Apoptosis and Autophagy

  2020cites this paper
• Mechanisms of resistance to T cell‐based immunotherapy in head and neck cancer

  2020cites this paper
• Lobaplatin induces pyroptosis through regulating cIAP1/2, Ripoptosome and ROS in nasopharyngeal carcinoma.

  2020cites this paper
• Isovaleroylbinankadsurin A ameliorates cardiac ischemia/reperfusion injury through activating GR dependent RISK signaling.

  2020cites this paper
• Necroptosis in head and neck squamous cell carcinoma: characterization of clinicopathological relevance and in vitro cell model

  2020cites this paper
• Association of CASP8 polymorphisms and cancer susceptibility: A meta-analysis.

  2020cites this paper
• Discovery of New Targets to Control Metastasis in Pancreatic Cancer by Single-cell Transcriptomics Analysis of Circulating Tumor Cells

  2020cites this paper
• Sensitization of head and neck squamous cell carcinoma to apoptosis by combinational SMAC mimetic and Fas ligand-Fc treatment in vitro.

  2020cites this paper
• The multiple roles of the IAP super-family in cancer.

  2020cites this paper
• Prognostic and Clinicopathological Significance of FADD Upregulation in Head and Neck Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis

  2020cites this paper
• BIRC2 Expression Impairs Anti-Cancer Immunity and Immunotherapy Efficacy.

  2020cites this paper
• Methyl Palmitate: the Naturally Occurring Cardioprotective Agent

  2020cites this paper
• Regulation of NFκB Signalling by Ubiquitination: A Potential Therapeutic Target in Head and Neck Squamous Cell Carcinoma?

  2020cites this paper
• Targeting pyroptosis to regulate ischemic stroke injury: molecular mechanisms and preclinical evidences.

  2020cites this paper
• Dynamic single-cell RNA sequencing identifies immunotherapy persister cells following PD-1 blockade.

  2020cites this paper
• OTUD7B suppresses Smac mimetic-induced lung cancer cell invasion and migration via deubiquitinating TRAF3

  2020cites this paper
• Targeting the Ubiquitin System in Glioblastoma

  2020cites this paper
• Development of Mirror-Image Screening Systems for XIAP BIR3 Domain Inhibitors.

  2019cites this paper
• Emerging Therapies for Acute Myelogenus Leukemia Patients Targeting Apoptosis and Mitochondrial Metabolism

  2019cites this paper